Literature DB >> 11708729

Immersive virtual environments in cue exposure.

M F Kuntze1, R Stoermer, R Mager, A Roessler, F Mueller-Spahn, A H Bullinger.   

Abstract

Cue reactivity to drug-related stimuli is a frequently observed phenomenon in drug addiction. Cue reactivity refers to a classical conditioned response pattern that occurs when an addicted subject is exposed to drug-related stimuli. This response consists of physiological and cognitive reactions. Craving, a subjective desire to use the drug of choice, is believed to play an important role in the occurrence of relapse in the natural setting. Besides craving, other subjective cue-elicited reactions have been reported, including withdrawal symptoms, drug-agonistic effects, and mood swings. Physiological reactions that have been investigated include skin conductance, heart rate, salivation, and body temperature. Conditioned reactivity to cues is an important factor in addiction to alcohol, nicotine, opiates, and cocaine. Cue exposure treatment (CET) refers to a manualized, repeated exposure to drug-related cues, aimed at the reduction of cue reactivity by extinction. In CET, different stimuli are presented, for example, slides, video tapes, pictures, or paraphernalia in nonrealistic, experimental settings. Most often assessments consist in subjective ratings by craving scales. Our pilot study will show that immersive virtual reality (IVR) is as good or even better in eliciting subjective and physiological craving symptoms as classical devices.

Entities:  

Mesh:

Year:  2001        PMID: 11708729     DOI: 10.1089/109493101750527051

Source DB:  PubMed          Journal:  Cyberpsychol Behav        ISSN: 1094-9313


  19 in total

1.  Methamphetamine craving induced in an online virtual reality environment.

Authors:  Christopher Culbertson; Sam Nicolas; Itay Zaharovits; Edythe D London; Richard De La Garza; Arthur L Brody; Thomas F Newton
Journal:  Pharmacol Biochem Behav       Date:  2010-07-17       Impact factor: 3.533

2.  Telemental health: A status update.

Authors:  Elias Aboujaoude; Wael Salame; Lama Naim
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 3.  The Use of Virtual Reality Technology in the Treatment of Anxiety and Other Psychiatric Disorders.

Authors:  Jessica L Maples-Keller; Brian E Bunnell; Sae-Jin Kim; Barbara O Rothbaum
Journal:  Harv Rev Psychiatry       Date:  2017 May/Jun       Impact factor: 3.732

Review 4.  Role of cues and contexts on drug-seeking behaviour.

Authors:  Christina J Perry; Isabel Zbukvic; Jee Hyun Kim; Andrew J Lawrence
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

5.  VIRTUAL REALITY CUE EXPOSURE THERAPY FOR THE TREATMENT OF TOBACCO DEPENDENCE.

Authors:  Christopher S Culbertson; Stephanie Shulenberger; Richard De La Garza; Thomas F Newton; Arthur L Brody
Journal:  J Cyber Ther Rehabil       Date:  2012

6.  Virtual Reality Educational Tool for Human Anatomy.

Authors:  Santiago González Izard; Juan A Juanes Méndez; Pablo Ruisoto Palomera
Journal:  J Med Syst       Date:  2017-03-22       Impact factor: 4.460

Review 7.  Learning to forget: manipulating extinction and reconsolidation processes to treat addiction.

Authors:  Mary M Torregrossa; Jane R Taylor
Journal:  Psychopharmacology (Berl)       Date:  2012-05-26       Impact factor: 4.530

8.  Cue reactivity in active pathological, abstinent pathological, and regular gamblers.

Authors:  Ruthlyn Sodano; Edelgard Wulfert
Journal:  J Gambl Stud       Date:  2009-08-07

Review 9.  Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction.

Authors:  Jane R Taylor; Peter Olausson; Jennifer J Quinn; Mary M Torregrossa
Journal:  Neuropharmacology       Date:  2008-07-30       Impact factor: 5.250

10.  Social pressure-induced craving in patients with alcohol dependence: application of virtual reality to coping skill training.

Authors:  Jung Suk Lee; Kee Namkoong; Jeonghun Ku; Sangwoo Cho; Ji Yeon Park; You Kyong Choi; Jae-Jin Kim; In Young Kim; Sun I Kim; Young-Chul Jung
Journal:  Psychiatry Investig       Date:  2008-12-31       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.